{"entity":{"type":"insider","cik":"0001652410","url":"/insider/0001652410","json_url":"/insider/0001652410.json","name":"Hecht Beth","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":15,"n_filings":14,"first":"2019-02-22","last":"2026-08-04","span_basis":"filed_date"},"name_variants":[{"name":"Hecht Beth","source":"filing","n_filings":14,"first_seen":"2019-02-22","last_seen":"2026-08-04"}],"transactions":[{"id":6174334,"accession":"0001652410-26-000016","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001652410-26-000016","line_url":"/filing/0001652410-26-000016#line-1","is_derivative":false,"issuer_cik":"0001652410","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001652410","owner_cik":"0001652410","owner_name":"Hecht Beth","owner_display_name":"Hecht Beth","owner_url":"/insider/0001652410","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16666.0,"shares_display":"16,666","price_per_share":8.0135,"price_display":"8.01","price_state":"stated","total_value":133552.991,"total_display":"133,552.99","total_whole":"133,553","shares_owned_after":1144462.0,"shares_owned_after_display":"1,144,462","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-03","filed_date":"2026-08-04","scope":"insider"},{"id":5815019,"accession":"0001652410-26-000014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001652410-26-000014","line_url":"/filing/0001652410-26-000014#line-1","is_derivative":false,"issuer_cik":"0001652410","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001652410","owner_cik":"0001652410","owner_name":"Hecht Beth","owner_display_name":"Hecht Beth","owner_url":"/insider/0001652410","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16666.0,"shares_display":"16,666","price_per_share":8.0319,"price_display":"8.03","price_state":"stated","total_value":133859.6454,"total_display":"133,859.65","total_whole":"133,860","shares_owned_after":1161128.0,"shares_owned_after_display":"1,161,128","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-07-01","filed_date":"2026-07-02","scope":"insider"},{"id":5840063,"accession":"0001652410-26-000012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001652410-26-000012","line_url":"/filing/0001652410-26-000012#line-1","is_derivative":false,"issuer_cik":"0001652410","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001652410","owner_cik":"0001652410","owner_name":"Hecht Beth","owner_display_name":"Hecht Beth","owner_url":"/insider/0001652410","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16667.0,"shares_display":"16,667","price_per_share":6.0588,"price_display":"6.06","price_state":"stated","total_value":100982.0196,"total_display":"100,982.02","total_whole":"100,982","shares_owned_after":1176506.0,"shares_owned_after_display":"1,176,506","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-06-01","filed_date":"2026-06-02","scope":"insider"},{"id":6024804,"accession":"0001652410-26-000010","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001652410-26-000010","line_url":"/filing/0001652410-26-000010#line-1","is_derivative":false,"issuer_cik":"0001652410","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001652410","owner_cik":"0001652410","owner_name":"Hecht Beth","owner_display_name":"Hecht Beth","owner_url":"/insider/0001652410","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16667.0,"shares_display":"16,667","price_per_share":6.2282,"price_display":"6.23","price_state":"stated","total_value":103805.4094,"total_display":"103,805.41","total_whole":"103,805","shares_owned_after":1193173.0,"shares_owned_after_display":"1,193,173","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-05-01","filed_date":"2026-05-01","scope":"insider"},{"id":5885235,"accession":"0001652410-26-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001652410-26-000008","line_url":"/filing/0001652410-26-000008#line-1","is_derivative":false,"issuer_cik":"0001652410","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001652410","owner_cik":"0001652410","owner_name":"Hecht Beth","owner_display_name":"Hecht Beth","owner_url":"/insider/0001652410","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16667.0,"shares_display":"16,667","price_per_share":5.9914,"price_display":"5.99","price_state":"stated","total_value":99858.6638,"total_display":"99,858.66","total_whole":"99,859","shares_owned_after":1209840.0,"shares_owned_after_display":"1,209,840","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-01","filed_date":"2026-04-03","scope":"insider"},{"id":5767052,"accession":"0001652410-26-000006","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001652410-26-000006","line_url":"/filing/0001652410-26-000006","is_derivative":false,"issuer_cik":"0001652410","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001652410","owner_cik":"0001652410","owner_name":"Hecht Beth","owner_display_name":"Hecht Beth","owner_url":"/insider/0001652410","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16667.0,"shares_display":"16,667","price_per_share":6.245019301613968,"price_display":"6.25","price_state":"stated","total_value":104085.7367,"total_display":"104,085.74","total_whole":"104,086","shares_owned_after":1226607.0,"shares_owned_after_display":"1,226,607","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-03-02","filed_date":"2026-03-04","scope":"insider","n_lines":2},{"id":5767050,"accession":"0001652410-26-000004","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001652410-26-000004","line_url":"/filing/0001652410-26-000004#line-5","is_derivative":false,"issuer_cik":"0001652410","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001652410","owner_cik":"0001652410","owner_name":"Hecht Beth","owner_display_name":"Hecht Beth","owner_url":"/insider/0001652410","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16667.0,"shares_display":"16,667","price_per_share":7.4487,"price_display":"7.45","price_state":"stated","total_value":124147.4829,"total_display":"124,147.48","total_whole":"124,147","shares_owned_after":1243174.0,"shares_owned_after_display":"1,243,174","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-02","filed_date":"2026-02-02","scope":"insider"},{"id":6097725,"accession":"0001652410-26-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001652410-26-000002","line_url":"/filing/0001652410-26-000002#line-1","is_derivative":false,"issuer_cik":"0001652410","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001652410","owner_cik":"0001652410","owner_name":"Hecht Beth","owner_display_name":"Hecht Beth","owner_url":"/insider/0001652410","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16667.0,"shares_display":"16,667","price_per_share":7.4264,"price_display":"7.43","price_state":"stated","total_value":123775.8088,"total_display":"123,775.81","total_whole":"123,776","shares_owned_after":1308103.0,"shares_owned_after_display":"1,308,103","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-02","filed_date":"2026-01-05","scope":"insider"},{"id":4961430,"accession":"0001652410-25-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001652410-25-000005","line_url":"/filing/0001652410-25-000005#line-1","is_derivative":false,"issuer_cik":"0001652410","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001652410","owner_cik":"0001652410","owner_name":"Hecht Beth","owner_display_name":"Hecht Beth","owner_url":"/insider/0001652410","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16667.0,"shares_display":"16,667","price_per_share":7.0067,"price_display":"7.01","price_state":"stated","total_value":116780.6689,"total_display":"116,780.67","total_whole":"116,781","shares_owned_after":1320176.0,"shares_owned_after_display":"1,320,176","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-01","filed_date":"2025-12-02","scope":"insider"},{"id":4308057,"accession":"0001652410-25-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001652410-25-000003","line_url":"/filing/0001652410-25-000003#line-1","is_derivative":false,"issuer_cik":"0001652410","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001652410","owner_cik":"0001652410","owner_name":"Hecht Beth","owner_display_name":"Hecht Beth","owner_url":"/insider/0001652410","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16667.0,"shares_display":"16,667","price_per_share":7.3976,"price_display":"7.40","price_state":"stated","total_value":123295.7992,"total_display":"123,295.80","total_whole":"123,296","shares_owned_after":1336843.0,"shares_owned_after_display":"1,336,843","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-11-11","filed_date":"2025-11-13","scope":"insider"},{"id":4214988,"accession":"0001867096-25-000047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001867096-25-000047","line_url":"/filing/0001867096-25-000047#line-1","is_derivative":false,"issuer_cik":"0001652410","issuer_name":"Xeris Biopharma Holdings, Inc.","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001652410","owner_cik":"0001652410","owner_name":"Hecht Beth","owner_display_name":"Hecht Beth","owner_url":"/insider/0001652410","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40000.0,"shares_display":"40,000","price_per_share":5.4311,"price_display":"5.43","price_state":"stated","total_value":217244.0,"total_display":"217,244.00","total_whole":"217,244","shares_owned_after":1353510.0,"shares_owned_after_display":"1,353,510","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-20","filed_date":"2025-03-21","scope":"insider"},{"id":3160955,"accession":"0000899243-20-008434","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-008434","line_url":"/filing/0000899243-20-008434#line-1","is_derivative":false,"issuer_cik":"0001346302","issuer_name":"XERIS PHARMACEUTICALS INC","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001346302","owner_cik":"0001652410","owner_name":"Hecht Beth","owner_display_name":"Hecht Beth","owner_url":"/insider/0001652410","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":1.97,"price_display":"1.97","price_state":"stated","total_value":7880.0,"total_display":"7,880.00","total_whole":"7,880","shares_owned_after":57083.0,"shares_owned_after_display":"57,083","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-13","filed_date":"2020-03-16","scope":"insider"},{"id":2541016,"accession":"0000899243-20-004913","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-20-004913","line_url":"/filing/0000899243-20-004913#line-1","is_derivative":false,"issuer_cik":"0001346302","issuer_name":"XERIS PHARMACEUTICALS INC","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001346302","owner_cik":"0001652410","owner_name":"Hecht Beth","owner_display_name":"Hecht Beth","owner_url":"/insider/0001652410","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4000.0,"shares_display":"4,000","price_per_share":4.15,"price_display":"4.15","price_state":"stated","total_value":16600.0,"total_display":"16,600.00","total_whole":"16,600","shares_owned_after":8083.0,"shares_owned_after_display":"8,083","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-14","filed_date":"2020-02-18","scope":"insider"},{"id":8502406,"accession":"0000899243-19-004561","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-004561","line_url":"/filing/0000899243-19-004561#line-1","is_derivative":false,"issuer_cik":"0001346302","issuer_name":"XERIS PHARMACEUTICALS INC","issuer_ticker":"XERS","issuer_name_source":null,"issuer_url":"/issuer/0001346302","owner_cik":"0001652410","owner_name":"Hecht Beth","owner_display_name":"Hecht Beth","owner_url":"/insider/0001652410","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2500.0,"shares_display":"2,500","price_per_share":10.0,"price_display":"10.00","price_state":"stated","total_value":25000.0,"total_display":"25,000.00","total_whole":"25,000","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-19","filed_date":"2019-02-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":15,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":12,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":15},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001867096","name":"Xeris Biopharma Holdings, Inc.","url":"/issuer/0001867096","role":"Officer","n_filings":11,"first_seen":"2025-03-21","last_seen":"2026-08-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001346302","name":"XERIS PHARMACEUTICALS INC","url":"/issuer/0001346302","role":"Officer","n_filings":3,"first_seen":"2019-02-22","last_seen":"2020-03-16"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001652410","retrieved_at":"2026-08-24T00:36:03+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}